NCT03471078 2023-09-28
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers
Sobi, Inc.
Phase 3 Completed
Clinical Trials
6 trialsNCT06001567 2023-09-14
Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Unknown
NCT04609891 2022-04-29
Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors
Anhui Provincial Cancer Hospital
Phase NA Completed
NCT05087459 2021-10-21
Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Unknown
NCT04896528 2021-05-21
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04797182 2021-03-15
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
Sun Yat-sen University
Phase 2 Unknown